相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase
Zhongjie Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Aspergiolides C and D: Spirocyclic Aromatic Polyketides with Potent Protein Kinase c-Met Inhibitory Effects
Lin Du et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
C-MET as a new therapeutic target for the development of novel anticancer drugs
Israel Canadas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Targeting the HGF/Met signalling pathway in cancer
Fabiola Cecchi et al.
EUROPEAN JOURNAL OF CANCER (2010)
Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
John Porter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Inhibition of HGF/MET as therapy for malignancy
Sanjay Naran et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Discovering Potent Inhibitors Against the β-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) of Helicobacter pylori: Structure-Based Design, Synthesis, Bioassay, and Crystal Structure Determination
Lingyan He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Identification of pyrrolo[2,1-f][1,2,4] triazine-based inhibitors of Met kinase
Gretchen M. Schroeder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors
Zhen-Wei Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Weon-Kyoo You et al.
BMB REPORTS (2008)
NK4 gene therapy targeting HGF-MET and angiogenesis
Kunio Matsumoto et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase
Brian K. Albrecht et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, synthesis, and biological evaluation of potent c-Met inhibitors
Noel D. D'Angelo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Paolo M. Comoglio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
C-met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations
Steven F. Bellon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mechanisms and significance of bifunctional NK4 in cancer treatment
K Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score
G Chen et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2005)
Hereditary papillary renal carcinoma type I
PG Dharmawardana et al.
CURRENT MOLECULAR MEDICINE (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Modified AutoDock for accurate docking of protein kinase inhibitors
OV Buzko et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
分享论文
